Meloxicam blocks neuroinflammation, but not depressive-like behaviors, in HIV-1 transgenic female rats

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Nemeth, Christina L ^a,b   Glasper, Erica R ^c   Harrell, Constance S ^a,b   Malviya, Sanjana A ^b   Otis, Jeffrey S ^b   Neigh, Gretchen N ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; MELOXICAM; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; THIAZINE DERIVATIVE; THIAZOLE DERIVATIVE;

ADOLESCENCE; ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN CELL; CELL PROLIFERATION; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; RAT; TRANSGENIC RAT; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; DRUG EFFECTS; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; METABOLISM; PATHOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANXIETY; BEHAVIOR, ANIMAL; CHEMOKINE CCL2; DEPRESSION; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; RATS; RATS, TRANSGENIC; THIAZINES; THIAZOLES;

EID: 84907481721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108399     Document Type: Article

References (59)

1. Simioni S, Cavassini M, Annoni J-M, Rimbault A, Bourquin I., et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS: 1243-1250. doi:10.1097/QAD.0b013e3283354a7b.
2. Hinkin C, Castellon S, Durvasula R., Hardy D, Lam M, et al. (2002) Medication adherence among HIV+ adults. Neurology 59: 1944-1950.
3. Lopes M (2012) Gender, HIV Status, and Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Psychiatry Interpers Biol Process: 384-391. doi:10.4088/JCP.10m06304.
4. Williams PL, Leister E, Chernoff M., Nachman S, Morse E, et al. (2010) Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-affected adolescents. AIDS Behav 14: 1072-1082. doi:10.1007/s10461-010-9782-0.
5. Mellins CA, Tassiopoulos K, Malee K., Moscicki A-B, Patton D, et al. (2014) Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS 25: 413-422. doi:10.1089/apc.2011.0025.
6. Byakika-Tusiime J, Crane J, Oyugi J.H., Ragland K., Kawuma A, et al. (2009) Longitudinal antiretroviral adherence in HIV+ Ugandan parents and their children initiating HAART in the MTCT-Plus family treatment model: role of depression in declining adherence over time. AIDS Behav 13 Suppl 1: 82-91. doi:10.1007/s10461-009-9546-x.
7. Bragança M, Palha A (2011) Depression and neurocognitive performance in Portuguese patients infected with HIV. AIDS Behav 15: 1879-1887. doi:10.1007/s10461-011-9973-3.
8. Paramesparan Y, Garvey L, Ashby J., Foster C, Fidler S, et al. (2010) High Rates of Asymptomatic Neurocogntivie Impairment in Vertically Acquired HIV-1-Infected Adolescents Survivng to Adulthood. J Acquir Immune Defic Syndr 55: 132-136.
9. Chaudoir SR, Norton WE, Earnshaw V.A., Moneyham L., Mugavero MJ, et al. (2011) Coping with HIV Stigma: Do Proactive Coping and Spiritual Peace Buffer the Effect of Stigma on Depression? AIDS Behav 16: 2382-2391. doi:10.1007/s10461-011-0039-3.
10. Neigh GN, Karelina K, Zhang N., Glasper ER, Owens MJ, et al. (2009) Cardiac arrest and cardiopulmonary resuscitation dysregulates the hypothalamic-pituitary-adrenal axis. J Cereb Blood Flow Metab 29: 1673-1682. doi:10.1038/jcbfm.2009.85.
11. Peng J, Vigorito M, Liu X., Zhou D, Wu X, et al. (2010) The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 218: 94-101. doi:10.1016/j.jneuroim.2009.09.014.
12. Ray P, Liu X-H, Robinson L, Reid W., Xu L, et al. (2003) A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney Int 63: 2242-2253.
13. Reid W, Sadowska M, Denaro F., Rao S, Foulke J, et al. (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. P Natl Acad Sci USA 98: 9271-9276. doi:10.1073/pnas.161290298.
14. Reid W, Abdelwahab S, Sadowska M., Huso D, Neal A, et al. (2004) HIV-1 transgenic rats develop T cell abnormalities. Virology 321: 111-119. doi:10.1016/j.virol.2003.12.010.
15. Vigorito M, LaShomb AL, Chang SL (2007) Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2: 319-328. doi:10.1007/s11481-007-9078-y.
16. Lashomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15: 14-24. doi:10.1080/13550280802232996.
17. Moran L, Aksenov M, Booze R., Webb K, Mactutus C (2013) Adolescent HIV-1 transgenic rats: Evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr HIV Res 10: 415-424.
18. Moran LM, Booze RM, Webb K.M., Mactutus CF (2013) Neurobehavioral alterations in HIV-1 transgenic rats: evidence for dopaminergic dysfunction. Exp Neurol 239: 139-147. doi:10.1016/j.expneurol.2012.10.008.
19. Rao JS, Kim H-W, Kellom M, Greenstein D., Chen M, et al. (2011) Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. J Neuroinflamm 8: 101. doi:10.1186/1742-2094-8-101.
20. National Survey on Drug Use and Health (2012) Depression triples between the ages of 12 and 15 among adolescent girls.
21. Kacanek D, Jacobson DL, Spiegelman D, Wanke C., Isaac R, et al. (2010) Incident depression symptoms are associated with poorer HAART adherence: a longitudinal analysis from the Nutrition for Healthy Living study. J Acquir Immune Defic Syndr 53: 266-272. doi:10.1097/QAI.0b013e3181b720e7.
22. Urbach YK, Bode FJ, Nguyen H.P., Riess O., Hörsten S Von (2010) Rat Genomics. Methods 597. doi:10.1007/978-1-60327-389-3.
23. Korenova M, Zilka N, Stozicka Z., Bugos O, Vanicky I, et al. (2009) NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy. J Neurosci Methods 177: 108-114. doi:10.1016/j.jneumeth.2008.09.027.
24. File SE, Hyde JR (1978) Can social interaction be used to measure anxiety? Br J Pharmacol 62: 19-24.
25. Willner P, Towell A, Sampson D., Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93: 358-364.
26. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33. doi:10.1016/S0014-2999(03)01272-X.
27. Porsolt R, Anton G, Blavet N., Jalfre M (1978) Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47: 379-391.
28. Goncalves MB, Williams E-J, Yip P, Yáñez-Muñoz RJ, Williams G, et al. (2010) The COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain. Br J Pharmacol 159: 1118-1125. doi:10.1111/j.1476-5381.2009.00618.x.
29. Jung K-H, Chu K., Lee S-T, Kim J, Sinn D-I, et al. (2006) Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus. Neurobiol Dis 23: 237-246. doi:10.1016/j.nbd.2006.02.016.
30. Russo I, Amornphimoltham P, Weigert R., Barlati S, Bosetti F (2011) Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation. Cell Cycle 10: 2568-2573. doi:10.4161/cc.10.15.15946.
31. Ahmed M, Khanna D, Furst DE (2005) Meloxicam in rheumatoid arthritis. Expert Opin Drug Metab Toxicol 1: 739-751. doi:10.1517/17425255.1.4.739.
32. Engelhardt G (1996) Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Br J Rheumatol 35 Suppl 1: 4-12.
33. Fischer CW, Liebenberg N, Elfving B., Lund S, Wegener G (2012) Isolation-induced behavioural changes in a genetic animal model of depression. Behav Brain Res 230: 85-91. doi:10.1016/j.bbr.2012.01.050.
34. Derntl B, Seidel E-M, Eickhoff SB, Kellermann T, Gur R.C., et al. (2011) Neural correlates of social approach and withdrawal in patients with major depression. Soc Neurosci 6: 482-501. doi:10.1080/17470919.2011.579800.
35. Detke MJ, Rickels M, Lucki I (1995) Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 121: 66-72.
36. Bourque SL, Adams MA, Nakatsu K, Winterborn A (2010) Comparison of buprenorphine and meloxicam for postsurgical analgesia in rats: effects on body weight, locomotor activity, and hemodynamic parameters. J Am Assoc Lab Anim Sci 49: 617-622.
37. Miller AH (2010) Depression and immunity: a role for T cells? Brain Behav Immun 24: 1-8. doi:10.1016/j.bbi.2009.09.009.
38. Frank-Cannon TC, Alto LT, McAlpine F.E., Tansey MG (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 4: 47. doi:10.1186/1750-1326-4-47.
39. Zanin V, Delbue S, Marcuzzi A., Tavazzi E, Del Savio R, et al. (2012) Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders. J Neurovirol 18: 416-422. doi:10.1007/s13365-012-0109-y.
40. Merrill JE, Chen ISY (1991) HIV-1, macrophages, glial cells and cytokines in AIDS nervous system disease. FASEB J 5: 2391-2397.
41. Kipnis J, Derecki NC, Yang C, Scrable H (2008) Immunity and cognition: what do age-related dementia, HIV-dementia and "chemo-brain" have in common? Trends Immunol 29: 455-463. doi:10.1016/j.it.2008.07.007.
42. Piletz JE, Halaris A, Iqbal O., Hoppensteadt D, Fareed J, et al. (2009) Pro-inflammatory biomakers in depression: treatment with venlafaxine. World J Biol Psychiatry 10: 313-323. doi:10.3109/15622970802573246.
43. Raison CL, Capuron L, Miller AH (2006) Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 27: 24-31. doi:10.1016/j.it.2005.11.006.
44. Suarez EC (2003) The Relation of Severity of Depressive Symptoms to Monocyte-Associated Proinflammatory Cytokines and Chemokines in Apparently Healthy Men. Psychosom Med 65: 362-368. doi:10.1097/01.PSY.0000035719.79068.2B.
45. Brabers NACH, Nottet HSLM (2006) Role of the pro-inflammatory cytokines TNF-α and IL-1β in HIV-associated dementia. Eur J Clin Invest: 447-458.
46. Taupin P (2008) Adult neurogenesis, neuroinflammation and therapeutic potential of adult neural stem cells. Int J Med Sci 5: 127-132.
47. Lawson MA, Kelley KW, Dantzer R (2011) Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: A possible mechanism for AIDS comorbid depression. Brain Behav Immun 25: 1569-1575. doi:10.1016/j.bbi.2011.05.006.
48. Royal W, Zhang L, Guo M., Jones O, Davis H, et al. (2012) Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat. J Neuroimmunol 247: 16-24. doi:10.1016/j.jneuroim.2012.03.015.
49. Scholzen T, Gerdes J (2000) The Ki-67 protein: From the known and the unknown. J Cell Phys 182: 311-322.
50. Sung Y-H, Shin M-S, Cho S, Baik H-H, Jin B-K, et al. (2010) Depression-like state in maternal rats induced by repeated separation of pups is accompanied by a decrease of cell proliferation and an increase of apoptosis in the hippocampus. Neurosci Lett 470: 86-90. doi:10.1016/j.neulet.2009.12.063.
51. Heine VM, Maslam S, Zareno J., Joels M, Lucassen PJ (2004) Suppressed proliferation and apoptotic changes in the rat dentate gyrus after acute and chronic stress are reversible. Eur J Neurosci 19: 131-144. doi:10.1046/j.1460-9568.2003.03100.x.
52. Campbell S, Macqueen G (2004) The role of the hippocampus in the pathophysiology of major depression. J Psych Neurosci 29: 417-426.
53. Sheline YI, Gado MH, Kraemer HC (2004) Untreated depression and hippocampal volume loss. Am J Psychiatry 161: 1309-1310.
54. Stockmeier CA, Mahajan GJ, Konick L.C., Overholser JC, Jurjus GJ, et al. (2004) Cellular changes in the postmortem hippocampus in major depression. Biol Psych 56: 640-650. doi:10.1016/j.biopsych.2004.08.022.
55. Kempermann G, Kronenberg G (2003) Depressed new Neurons?-Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psych 54: 499-503. doi:10.1016/S0006-3223(03)00319-6.
56. Boldrini M, Underwood MD, Hen R, Rosoklija G.B., Dwork AJ, et al. (2009) Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34: 2376-2389. doi:10.1038/npp.2009.75.
57. Duman RS, Nakagawa S, Malberg J (2001) Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25: 836-844. doi:10.1016/S0893-133X(01)00358-X.
58. Walkup J, Wei W, Sambamoorthi U., Crystal S (2008) Antidepressant treatment and adherence to combination antiretroviral therapies among patients with AIDS and diagnosed depression. Psychiatr Q 79: 43-53. doi:10.1007/s11126-007-9055-x.
59. Koenig LJ, Nesheim S, Abramowitz S (2011) Adolescents with perinatally acquired HIV: emerging behavioral and health needs for long-term survivors. Curr Opin Obstet Gynecol 23: 321-327. doi:10.1097/GCO.0b013e32834a581b.